The upregulation of Bcl-xL expression enhances uncontrolled cell proliferation in estrogen-dependent breast cancer, a phenomenon that can be reversed by the knockdown of hnRNPA2B1 (35). Here, HNRNPA2B1 is linked to breast cancer.